N@N

VRTX, RMBS, MET, VAR, VGZ, CRZO, Expected to Trade Lower After Bearish Insider Trading

October 7, 2016 / M2 PRESSWIRE / BUYINS.NET / http://www.squeezetrigger.com is monitoring top insider trading patterns and these stocks are the most likely to trade Lower in the next 6 months. Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), Rambus Inc. (NASDAQ:RMBS), MetLife Inc. (NYSE:MET), Varian Medical Systems Inc. (NYSE:VAR), Vista Gold Corp. (NYSE:VGZ), Carrizo Oil & Gas Inc. (NASDAQ:CRZO) are all expected to go Lower as Sell signals have been generated by top insider trading patterns. The most important data elements considered when performing insider analysis are: Insiders Track Record - An insiders track record is best summarized by the Insider Score which ranges from 1 (least predictive) to 100 (most predictive) based on prior trading performance. In addition, the actual returns following the insiders prior trades are included to determine the potential magnitude of future returns. Insiders Role - Trades by higher-level insiders are generally more predictive than trades by lower level insiders. Higher-level insiders to include Chairman (CB), Chief Executive Officer (CEO), President (P), Chief Financial Officer (CFO), and Vice Chairman (VC).

The chart below displays the stocks expected to go Lower along with the insider name, position, predictive insider score, 6 month expected return and number of trading decisions included in the score.

  Symbol  Company Name                     Insider Name                     Role     Shares      Insider Score  Avg 6 Month Return  # of Dec. 
  VRTX    Vertex Pharmaceuticals Incorporated  Arbuckle, Stuart A               O        1,208       88             -9.3%               15        
  RMBS    Rambus Inc.                      Herscher, Penelope A             D        6,809       76             -7.1%               6         
  MET     MetLife Inc.                     Morris, Maria R                  O        8,800       84             -3.7%               24        
  VAR     Varian Medical Systems Inc.      Wilson, Dow R                    CEO      10,000      98             -7.5%               31        
  VGZ     Vista Gold Corp.                 Richings, Michael B              D        31,600      84             -18.6%              2         
  CRZO    Carrizo Oil & Gas Inc.           Ramsey, Roger A                  D        1,000       87             -13.2%              8         

The insider buying report presents recent insider purchases, reported on Forms 3, 4, and 5 filed with the SEC. The transactions are aggregated to a 'decision' level which simplifies the data analysis. A decision is a grouping of buying or selling by an individual at the specified company.

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - Vertex Pharmaceuticals Incorporated engages in discovering, developing, manufacturing, and commercializing medicines for serious diseases. The company focuses on developing and commercializing therapies for the treatment of cystic fibrosis (CF) and advancing its research and development programs. It markets ORKAMBI for the treatment of patients with CF 12 years of age and older who have two copies (homozygous) of the F508del mutation in their CFTR gene; and KALYDECO (ivacaftor) for the treatment of patients with CF 6 years of age and older who have the G551D mutation in their CFTR gene. The company also develops VX-661, a corrector compound that is in a Phase III development stage in combination with ivacaftor in multiple CF patients; VX-371, an investigational epithelial sodium channel, which is in a Phase II development stage; and VX-152 and VX-440 that are CFTR corrector compounds in Phase I clinical trial. In addition, it engages in the research and mid-and early-stage development programs in the areas of oncology, pain, and neurology. The company sells its products primarily to specialty pharmacy providers and wholesalers in North America, as well as government-owned and supported customers in international markets. Vertex Pharmaceuticals Incorporated has collaborations with Cystic Fibrosis Foundation Therapeutics Incorporated; Parion Sciences, Inc.; CRISPR Therapeutics AG; BioAxone Biosciences, Inc.; Janssen Pharmaceuticals, Inc.; and Moderna Therapeutics, Inc. The company was founded in 1989 and is headquartered in Boston, Massachusetts..

Rambus Inc. (NASDAQ:RMBS) - Rambus Inc. manufactures and sells semiconductor and IP products, spanning memory, and interfaces to security, smart sensors, and lighting industries in South Korea and internationally. It has four operational units: Memory and Interfaces Division, Cryptography Research Division, Emerging Solutions Division, and Lighting and Display Technologies. It focuses on designing, developing, and licensing technology that is related to memory and interfaces; and providing various services, including know-how and technology transfer, product design and development, system integration, and other services. The company also focuses on the design, development, and licensing of technologies for chip and system security, anti-counterfeiting, smart ticketing, and mobile payments; and technologies for lighting. Rambus Inc. was founded in 1990 and is headquartered in Sunnyvale, California..

MetLife Inc. (NYSE:MET) - MetLife, Inc. provides life insurance, annuities, employee benefits, and asset management products in the United States, Japan, Latin America, Asia, Europe, and the Middle East. It operates in six segments: Retail; Group, Voluntary & Worksite Benefits; Corporate Benefit Funding; Latin America; Asia; and Europe, the Middle East and Africa. The company provides variable, universal, term, and whole life products; individual disability income products; personal lines property and casualty insurance, including private passenger automobile, homeowners, and personal excess liability insurance; and variable and fixed annuities for asset accumulation and distribution needs, as well as mutual funds and other securities products. It also offers group insurance products, such as variable, universal, and term life products; dental, group short- and long-term disability, and accidental death and dismemberment coverages; and voluntary and worksite products consisting of personal lines property and casualty insurance, as well as LTC, prepaid legal plans, and critical illness products. In addition, the company provides annuity and investment products comprising guaranteed interest products and other stable value products, income annuities, and separate account contracts for the investment management of defined benefit and defined contribution plan assets; and structured settlements and products to fund postretirement benefits and company-, bank- or trust-owned life insurance, as well as health insurance, group medical, credit insurance, endowment, retirement, and savings products. It serves individuals and corporations, as well as other institutions and their employees. The company sells its products through sales forces, third-party organizations, independent agents, and property and casualty specialists, as well as through career agency, bancassurance, direct marketing, brokerage, and e-commerce channels. MetLife, Inc. was founded in 1863 and is based in New York, New York..

Varian Medical Systems Inc. (NYSE:VAR) - Varian Medical Systems, Inc. designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. Its Oncology Systems segment provides hardware and software products for treating cancer with radiotherapy, fixed field intensity-modulated radiation therapy, image-guided radiation therapy, volumetric modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, and brachytherapy. Its products include linear accelerators, brachytherapy afterloaders, treatment simulation, verification equipment, and accessories; and information management, treatment planning, image processing, clinical knowledge exchange, patient care management, decision-making support, and practice management software. This segment serves university research and community hospitals, private and governmental institutions, healthcare agencies, physicians offices, oncology practices, radiotherapy centers, and cancer care clinics. The company s Imaging Components segment provides X-ray imaging components for use in radiographic or fluoroscopic imaging, mammography, special procedures, computed tomography, computer aided diagnostics, and industrial applications. It sells its products to original equipment manufacturers, independent service companies, and end-users. This segment also offers Linatron X-ray accelerators, imaging processing software, and image detection products for security and inspection purposes. In addition, Varian Medical Systems, Inc. provides products and systems for delivering proton therapy; and develops various technologies in the areas of digital X-ray imaging, volumetric and functional imaging, and improved X-ray sources. The company was formerly known as Varian Associates, Inc. and changed its name to Varian Medical Systems, Inc. in April 1999. Varian Medical Systems, Inc. was founded in 1948 and is headquartered in Palo Alto, California..

Vista Gold Corp. (NYSE:VGZ) - Vista Gold Corp. focuses on the evaluation, acquisition, exploration, and advancement of gold exploration and potential development projects principally in Australia and North America. It primarily holds interest in the Mt Todd gold project located in Northern Territory, Australia. The company was founded in 1983 and is based in Littleton, Colorado..

Carrizo Oil & Gas Inc. (NASDAQ:CRZO) - Carrizo Oil & Gas, Inc., together with its subsidiaries, engages in the exploration, development, and production of oil and gas primarily in the United States. The company holds interests in oil and gas plays, including Eagle Ford Shale in Texas; the Delaware Basin in West Texas; the Utica Shale in Ohio; the Niobrara Formation in Colorado; and the Marcellus Shale in Pennsylvania. As of December 31, 2015, it had proved oil and gas reserves of 170.6 million barrels of oil equivalent; and operated 474 gross productive oil and gas wells. The company was founded in 1993 and is based in Houston, Texas..

About BUYINS.NET

BUYINS.NET, http://www.buyins.net, monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS Friction Factor - Market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements" Naked Shorts (RegSho) - Tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING Earnings - Predicts probability, price move and length of move before and after all US stock earnings reports Seasonality - Predicts probability, price move and length of move based on exact time of year for all US stocks Group Correlation - Tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups SqueezeTrigger - Massive database that tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock. Valuation - Tracks all known valuation models and applies them. GATS - Tracks and quantifies known trading strategies by backtesting, optimizing and running genetic algorithms and neural networks to ascertain best trading strategies. PatternScan - Automates tracking of every technical pattern and predicts next move in stocks. Insider - Tracks insiders trading records and determines trading performance. Trades by higher-level insiders are generally more predictive than trades by lower level insiders Events - Tracks patterns directly correlated to specific events.

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. [symbol] has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net, for complete risks and disclosures.

Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net

Contributing Sources

---